
Elevated Plus Maze
From $1,890.00
Research data · Animal model and test
From 2021 to 2025, 43 animal research papers mentioned scopolamine and the elevated plus maze in their title or abstract.
That is about the same as the 42 papers of 2011 to 2015. Between the same two periods, the papers that mention scopolamine and any of the 90 tests we count rose 24%. The 2021 to 2025 count may run low because of a dip in PubMed's indexing, explained under the year chart.
The elevated plus maze among what labs pair with scopolamine. Each line joins scopolamine to a behavioral test or disease model mentioned with it in papers from 2021 to 2025. The more papers mention both, the wider the line. The line to the elevated plus maze is highlighted.
Tap or click a dot to see its papers. Tap or click it again to open its page.
Compare with another test in papers that mention scopolamine, or with the elevated plus maze in papers that mention another model or technique. Your pick shows as a line over the bars.
Animal research papers that mention scopolamine and the elevated plus maze, by year, 2001 to 2026
The 2026 bar counts papers added to PubMed by November 8, 2026.
| Year | Papers |
|---|---|
| 2001 | 5 |
| 2002 | 4 |
| 2003 | 1 |
| 2004 | 6 |
| 2005 | 4 |
| 2006 | 8 |
| 2007 | 5 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 7 |
| 2011 | 8 |
| 2012 | 12 |
| 2013 | 6 |
| 2014 | 6 |
| 2015 | 10 |
| 2016 | 14 |
| 2017 | 9 |
| 2018 | 14 |
| 2019 | 12 |
| 2020 | 7 |
| 2021 | 15 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 9 |
| 2025 | 7 |
| 2026 so far | 15 |
Papers that mention scopolamine and the elevated plus maze fell from 15 in 2021 to 5 in 2022, then rose to 7 in 2025. Part of this dip may come from PubMed's indexing rather than from fewer studies. We take a paper's species from PubMed's indexing when the indexing names one. Otherwise PubTator 3, NCBI's text-mining service, has to find a species in the title or abstract, or the paper is not counted. Papers that PubMed indexed under the subject heading Animals also fell and rose, from 200,221 in 2021 to 156,447 in 2023 and 235,479 in 2025.
Each bar is a share of the 43 papers from 2021 to 2025. A paper can use more than one species, so the shares can add to more than 100%.
Our store sells one product for this test.

From $1,890.00
Each bar is one test, with how many of the 43 papers also mention it, and what share that is. Of these papers, 5 (12%) mention no other test.
A paper counts here when it is animal research and its title or abstract mentions scopolamine and the elevated plus maze.
A paper that mentions either only in its methods is missed, so the count runs low. The search terms are in the list of models and techniques and the test list. The full method, with each source and its terms of use, is on our main page, Behavioral tests in published research.
A test mentioned with an animal model in 30 or more papers from 2021 to 2025 has a page like this one. Each name below opens its page.
Papers from 2021 to 2025
Papers from 2021 to 2025
The page on the elevated plus maze counts all the papers that mention it, whatever they study. The page on scopolamine ranks the tests mentioned with it.
ConductScience. (2026, November 13). Elevated plus maze with scopolamine [Data set]. https://conductscience.com/data/animal-models/scopolamine/elevated-plus-maze
@misc{conductscience_scopolamine_elevated_plus_maze_2026,
author = {{ConductScience}},
title = {Elevated plus maze with scopolamine},
year = {2026},
month = nov,
url = {https://conductscience.com/data/animal-models/scopolamine/elevated-plus-maze},
note = {Data set, released November 13, 2026},
}In the test battery tool, pick every test your study will run and add the apparatus we sell for them to one quote.